Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO. (2019)
Attributed to:
MICA: Towards using historical data for research prioritisation in children
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0215739
PubMed Identifier: 31166977
Publication URI: http://europepmc.org/abstract/MED/31166977
Type: Journal Article/Review
Volume: 14
Parent Publication: PloS one
Issue: 6
ISSN: 1932-6203